ArticleOncoscience2016
Bevacizumab in HER2-negative inflammatory breast cancer.
François Bertucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
2 papers cite it
this papercites it
ArticleOncoscience2016
François Bertucci et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.